Showing 3,501 - 3,520 results of 24,535 for search 'LiveAD~', query time: 5.77s Refine Results
  1. 3501
  2. 3502

    Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis by S. I. Pavlovich, T. M. Bryzgina, N. V. Makogon, L. I. Aleksyuk, T. V. Martynova, R. I. Yanchy, I. N. Alekseyeva

    Published 2011-12-01
    “…Aim of investigation. To study damage of liver tissue, its infiltration by cells of innate and adaptive immunity and cell deathin the development of concanavalin (ConA)-induced hepatitis in mice.Material and methods. …”
    Get full text
    Article
  3. 3503

    Thyroid Hormone-Induced Cytosol-to-Nuclear Translocation of Rat Liver Nrf2 Is Dependent on Kupffer Cell Functioning by Luis A. Videla, Pamela Cornejo, Pamela Romanque, Catherine Santibáñez, Iván Castillo, Romina Vargas

    Published 2012-01-01
    “…L-3,3′,5-triiodothyronine (T3) administration upregulates nuclear factor-E2-related factor 2 (Nrf2) in rat liver, which is redox-sensitive transcription factor mediating cytoprotection. …”
    Get full text
    Article
  4. 3504
  5. 3505
  6. 3506

    Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging by René Hako, Pavol Kristian, Peter Jarčuška, Ivana Haková, Ivana Hockicková, Ivan Schréter, Martin Janičko

    Published 2019-01-01
    “…To develop a noninvasive magnetic resonance imaging (MRI) method for evaluation of liver fibrosis. We evaluate the utility of hepatocyte-phase Gadoxetate disodium–enhanced magnetic resonance (MR) imaging in staging hepatic fibrosis and compare it with histological analysis as the reference standard (liver biopsy). …”
    Get full text
    Article
  7. 3507

    Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation by Christin Bürger, Miriam Maschmeier, Anna Hüsing-Kabar, Christian Wilms, Michael Köhler, Martina Schmidt, Hartmut H. Schmidt, Iyad Kabar

    Published 2019-01-01
    “…Background. Liver transplantation (LT) is a curative treatment for hepatocellular carcinoma (HCC) and the underlying primary liver disease; however, tumor recurrence is still a major issue. …”
    Get full text
    Article
  8. 3508

    Long-Term and Short-Term Effects of Hemodialysis on Liver Function Evaluated Using the Galactose Single-Point Test by Yi-Chou Hou, Wen-Chih Liu, Min-Tser Liao, Kuo-Cheng Lu, Lan Lo, Heng-Chih Pan, Chia-Chao Wu, Oliver Yoa-Pu Hu, Hung-Shang Tang

    Published 2014-01-01
    “…The galactose single-point (GSP) test assesses functioning liver mass by measuring the galactose concentration in the blood 1 hour after its administration. …”
    Get full text
    Article
  9. 3509

    Ligation of Left Renal Vein for Spontaneous Splenorenal Shunt to Prevent Portal Hypoperfusion after Orthotopic Liver Transplantation by Lampros Kousoulas, Kristina Imeen Ringe, Michael Winkler, Frank Lehner, Nicolas Richter, Juergen Klempnauer, Fabian Helfritz

    Published 2013-01-01
    “…We report a case of recovered portal flow by ligation of the left renal vein on the first postoperative day after orthotopic liver transplantation of a 54-year-old female with alcoholic liver cirrhosis, chronic kidney failure, and spontaneous splenorenal shunt. …”
    Get full text
    Article
  10. 3510
  11. 3511
  12. 3512

    Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure by Yunxia Tang, Qiongshu Li, Fanwei Meng, Xingyu Huang, Chan Li, Xin Zhou, Xiaoping Zeng, Yixin He, Jia Liu, Xiang Hu, Ji-Fan Hu, Tao Li

    Published 2016-01-01
    “…In this study, we investigated the therapeutic potential of UCMSCs that overexpress hepatocyte growth factor (HGF) in an acetaminophen-induced acute liver failure mouse model. We found that the HGF-UCMSC cell therapy protected animals from acute liver failure by reducing liver damage and prolonging animal survival. …”
    Get full text
    Article
  13. 3513

    Positive Leukocyte Esterase Dipstick Test: Association With Spontaneous Bacterial Peritonitis In Patients Suffering From Liver Cirrhosis by Sumbul Shahzadi, Fuad Ahmad Siddiqi, Imran Khan, Kanaz Ahmad Siddiqi, Javed Ahmad Khan, Ayesha Ashraf Cheema

    Published 2024-09-01
    “…This study included a total of 65 patients with liver cirrhosis with ascites that fulfilled the exclusion and inclusion criteria. 50 mL of ascitic fluid was drawn from every patient. …”
    Get full text
    Article
  14. 3514

    Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment by Harshal Rajekar, Kashan Bogammana, Richard S. Stubbs

    Published 2011-01-01
    “…Nonresectable neuroendocrine tumour (NET) liver metastases respond poorly to most widely available and used therapies. …”
    Get full text
    Article
  15. 3515

    A novel cytoprotective organ perfusion platform for reconstructing homeostasis of DCD liver while alleviating IRI injury by Tingting Lan, Mingxing Yu, Tao Ming, Hong Wang, Juan Deng, Shuhan Cheng, Zhongyang Shen, Deling Kong

    Published 2025-01-01
    “…However, the continuous extrusion forming with the rigid stationary shaft of the peristaltic pumps can damage cells, leading to metabolic disorders and eventual dysfunction of transplanted organs. …”
    Get full text
    Article
  16. 3516
  17. 3517

    Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice by James W. Perfield, Laura C. Ortinau, R. Taylor Pickering, Meghan L. Ruebel, Grace M. Meers, R. Scott Rector

    Published 2013-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) is strongly linked to obesity, insulin resistance, and abnormal hepatic lipid metabolism; however, the precise regulation of these processes remains poorly understood. …”
    Get full text
    Article
  18. 3518

    ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer by Yang-Hsiang Lin, Cheng-Yi Chen, Hsiang-Cheng Chi, Meng-Han Wu, Ming-Wei Lai, Chau-Ting Yeh

    Published 2025-02-01
    “…Liver cancer, encompassing hepatocellular carcinoma (HCC) and hepatoblastoma, the latter of which primarily occurs in early childhood, is the most common malignant tumor arising from liver and is responsible for a significant number of cancer-related deaths worldwide. …”
    Get full text
    Article
  19. 3519
  20. 3520